A detailed history of Evergreen Capital Management LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 16,915 shares of ZNTL stock, worth $31,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,915
Previous 16,915 -0.0%
Holding current value
$31,969
Previous $69,000 10.14%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.09 - $16.13 $400 - $1,580
-98 Reduced 0.58%
16,915 $69,000
Q1 2024

May 15, 2024

BUY
$10.83 - $16.49 $1,061 - $1,616
98 Added 0.58%
17,013 $268,000
Q3 2022

Nov 14, 2022

BUY
$20.23 - $31.73 $342,190 - $536,712
16,915 New
16,915 $366,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $108M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.